EN
HI
Summary
As of 22 Sep, 2026, Piramal Pharma stock price is ₹210.12. During the trading session, the stock has moved between an intraday low of ₹209.50 and an intraday high of ₹215.97. Over the last 52 weeks, Piramal Pharma has traded between ₹132.30 and ₹231.93.
The stock has recorded a trading volume of 24,70,090 shares,. Its Average Traded Price (ATP) is ₹212.21, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 23 @ ₹210.12.
Piramal Pharma has an upper circuit limit of ₹257.59 and a lower circuit limit of ₹171.73. The total value traded stands at ₹52.42 CR, and the delivery percentage for the day is 36.73%.
The stock is currently traded with a market lot size of 1. Piramal Pharma also offers a dividend yield of 0%.
Piramal Pharma Share Price Chart
Piramal Pharma Share Key Metrics
Volume
24.70 L
Market Cap
27974.29 CR
LTQ@LTP
23@210.12
ATP
212.21
Var Margin
18.19 %
Circuit Range
171.73-257.59
Delivery %
36.73 %
Value
52.42 CR
ASM/GSM
No
Market Lot
1
Piramal Pharma Fundamentals
P/E Ratio
0
P/B Ratio
3.57
Div. Yield
0
Sector P/E
37.95
Sector P/B
3.67
Sec. Div. Yield
0.51
Piramal Pharma Resistance and Support
Pivot 213.01
Resistance
First Resistance
218.34
Second Resistance
222.03
Third Resistance
227.36
Support
First Support
209.32
Second Support
203.99
Third Support
200.3
Piramal Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Sep 22 2026 | 215.5 | 210.12 | -2.11% | 215.97 | 209.5 |
| Mon Sep 21 2026 | 208.75 | 214.66 | 3.12% | 216.69 | 207.67 |
| Fri Sep 18 2026 | 204.44 | 208.16 | 1.69% | 210.1 | 204.44 |
Piramal Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-29 | Quarterly Results |
| 2026-04-28 | Audited Results |
| 2026-01-28 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-07-28 | Quarterly Results |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
Piramal Pharma News
Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - FDA Inspection
Piramal Pharma's Morpeth, UK facility was issued a US FDA Form-483 with 7 observations following a GMP inspection. The company is preparing a detailed response to address these observations.
Sep 14 2026 19:50:21
Piramal Pharma Management
| Name | Position |
|---|---|
| Nandini Piramal | Chairperson |
| Maneesh Sharma | Company Secretary and Compliance Officer |
Piramal Pharma Similar Stocks
Wockhardt Ltd.
2185.40
-1.90 (0.09%)
Dr. Lal Pathlabs Ltd.
1909.80
-10.60 (0.55%)
Neuland Laboratories Ltd.
22550.00
-60.00 (0.27%)
Rubicon Research Ltd.
1671.20
-61.40 (3.54%)
Acutaas Chemicals Ltd.
3213.70
-212.00 (6.19%)
Granules India Ltd.
864.05
-11.10 (1.27%)
Caplin Point Laboratories Ltd.
2777.30
20.70 (0.75%)
Shilpa Medicare Ltd.
1033.15
-37.65 (3.52%)
Astrazeneca Pharma India Ltd.
6711.50
61.50 (0.92%)
Eris Lifesciences Ltd.
1271.20
-24.10 (1.86%)
Piramal Pharma FAQs
The Buying Price of Piramal Pharma share is 210.12 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Piramal Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Piramal Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Piramal Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Piramal Pharma shares is 3.57. Useful to assess the stock's value relative to its book value.
To assess Piramal Pharma’s valuation compare Sector P/E, P/B which are 37.95 & 3.67 with sector averages, along with growth rates and financial metrics.
The Market Cap of Piramal Pharma is 27974.29 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Piramal Pharma share price is 231.93 & 132.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Piramal Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in PPLPHARMA
